EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Chlamydia trachomatis Seroassays Used in Epidemiologic Research: A Narrative Review and Practical Considerations

Mary Bridget Waters iD, Kevin Hybiske iD, Ren Ikeda, Bernhard Kaltenboeck, Lisa E Manhart iD, Kristen M Kreisel iD, Christine M Khosropour iD

The Journal of Infectious Diseases · 25.07.2024 · 230 (1) · 250-262

DOI: 10.1093/infdis/jiae199 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 19.04.2024. Verfasst von Mary Bridget Waters und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology. Hauptthemen laut MEDLINE: Chlamydia trachomatis, Chlamydia Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, NIAID NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chlamydia trachomatis (CT) is a sexually transmitted infection that can lead to adverse reproductive health outcomes. CT prevalence estimates are primarily derived from screening using nucleic acid amplification tests (NAATs). However, screening guidelines in the United States only include particular subpopulations, and NAATs only detect current infections. In contrast, seroassays identify past CT infections, which is important for understanding the public health impacts of CT, including pelvic inflammatory disease and tubal factor infertility. Older seroassays have been plagued by low sensitivity and specificity and have not been validated using a consistent reference measure, making it challenging to compare studies, define the epidemiology of CT, and determine the effectiveness of control programs. Newer seroassays have better performance characteristics. This narrative review summarizes the “state of the science” for CT seroassays that have been applied in epidemiologic studies and provides practical considerations for interpreting the literature and employing seroassays in future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chlamydia trachomatisChlamydia InfectionsHumansSensitivity and SpecificityFemalePrevalenceNucleic Acid Amplification TechniquesUnited StatesEpidemiologic Studies

Stichwörter der Autor:innen

Chlamydia trachomatisantibodiesepidemiologyserology

Autor:innen und Institutionen

  • Department of Epidemiology.
  • Department of Medicine, University of Washington, Seattle.
  • Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, Alabama.
  • Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.

ORCID-Profile: Mary Bridget Waters, Kevin Hybiske, Lisa E Manhart, Kristen M Kreisel, Christine M Khosropour

Förderung

  • Intramural CDC HHS
  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Waters, M. B., Hybiske, K., Ikeda, R., Kaltenboeck, B., Manhart, L. E., Kreisel, K. M., & Khosropour, C. M. (2024). Chlamydia trachomatis Seroassays Used in Epidemiologic Research: A Narrative Review and Practical Considerations. The Journal of Infectious Diseases, 230(1), 250-262. https://doi.org/10.1093/infdis/jiae199

Vancouver

Waters MB, Hybiske K, Ikeda R, Kaltenboeck B, Manhart LE, Kreisel KM, et al. Chlamydia trachomatis Seroassays Used in Epidemiologic Research: A Narrative Review and Practical Considerations. The Journal of Infectious Diseases. 2024;230(1):250-262. doi:10.1093/infdis/jiae199

BibTeX
@article{Waters2024,
  author = {Waters, Mary Bridget and Hybiske, Kevin and Ikeda, Ren and Kaltenboeck, Bernhard and Manhart, Lisa E and Kreisel, Kristen M and Khosropour, Christine M},
  title = {Chlamydia trachomatis Seroassays Used in Epidemiologic Research: A Narrative Review and Practical Considerations},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  volume = {230},
  number = {1},
  pages = {250--262},
  doi = {10.1093/infdis/jiae199}
}
Kostenlos starten →